It was another meaningful and engaging gathering for the society and trainees from across the

Asia Pacific region as we convened for the 2026 Highlights of ASH in Asia Pacific, held in

Malaysia. The event brought together hematology experts, fellows, and practitioners in a

collaborative environment that fostered both learning and regional camaraderie.

In contrast to previous years, the program was structured such that the first two days were

dedicated to the main scientific sessions, while the Clinical Research Trainee Day was

conducted on the third day. This allowed fellows to first immerse themselves in the latest

updates in hematology before transitioning into a more interactive and collaborative learning

experience.

The scientific sessions over the first two days were highly engaging, with topics that were not

only timely but also very relatable and practical to local clinical practice. Discussions covered

evolving treatment paradigms in acute leukemias and lymphomas, advances in

immunotherapy, transplantation, thrombosis, and cellular therapies, as well as the emerging

role of artificial intelligence in hematology. The sessions were complemented by dynamic panel

discussions that encouraged participation and critical exchange of ideas.

The fellows actively engaged in the discussions, raising practical and clinically relevant concerns.

Dr. Rene Amadore Jr., fellow from PGH, inquired about the utility of the Mentzer index in

differentiating iron deficiency anemia from thalassemia in pregnant patients, and sought expert

opinion on the use of sucrosomial iron as an alternative for those with intolerance to

conventional oral preparations, while also questioning the routine use of ferritin testing in

pregnancy despite recommendations for iron supplementation in standard reference

textbooks. Meanwhile, Dr. Kristian David, fellow from UST, raised questions on pragmatic

approaches to disease monitoring in low- to middle-income settings, particularly the possible

use of serum biomarkers such as LDH and beta-2 microglobulin when MRD assessment is not

readily available.

The “Lunch with the Experts” sessions remained a highlight of the program, providing delegates

with valuable opportunities for small-group discussions with internationally recognized

hematologists. These interactions allowed for deeper exploration of clinical dilemmas and

practical management strategies, further enriching the overall learning experience.

On the third day, fellows participated in the Clinical Research Trainee Day, where they were

grouped into small teams alongside renowned hematologists from different parts of the world.

The intimate setting fostered open discussion, collaboration, and mentorship, allowing

participants to gain meaningful insights into research development, study design, and academic

growth. The experience was widely regarded as highly impactful and instrumental in shaping

the fellows’ perspectives as future clinician-researchers.

Beyond the academic sessions, attendees also had the opportunity to appreciate the rich

culture of Malaysia. The group visited iconic landmarks such as the Petronas Twin Towers and

Batu Caves, and enjoyed local cuisine together with PCHTM leaders and officers. These shared

experiences further strengthened professional relationships and camaraderie among

participants.

Overall, the 2026 Highlights of ASH in Asia Pacific (Malaysia) successfully delivered a program

that was academically robust, highly engaging, and grounded in real-world applicability. The

meeting once again emphasized the value of regional collaboration in advancing hematology

education, research, and patient care.